For decades, neurology treated the brain like a black box, nudging it with drugs and hoping symptoms would ease. Now ...

Medtronic, a global leader in healthcare technology, today announced the launch of its pioneering Mobile Surgi-skill Lab- a ...

MiniMed is pitching the breadth of its portfolio as an advantage over more focused rivals such as Dexcom and Insulet.

This is where things get really forward-thinking. Medtronic GPT is starting to use predictive analytics to spot diseases even ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that its Diabetes business, which ...

Medtronic (MDT) is a strong defensive investment with stable growth, 49 years of dividend increases, and fair value. Read ...

MiniMed intends to apply to have its common stock listed on the Nasdaq Global Select Market under the symbol MMED. The number of shares to be offered and the price range for the offering have not yet ...

Rising prevalence of valvular heart diseases, expanding elderly population, and growing preference for minimally invasive cardiac procedures are driving the transcatheter heart valve replacement ...

Medtronic earned regulatory clearance in the U.S. for its Hugo robotic-assisted surgery system. This device will take time to ...

Medtronic’s Hugo robotic surgery system earns FDA clearance, ending Intuitive’s long-held dominance and reshaping the future of soft-tissue robotics.

The board of directors of (NYSE: MDT) on Thursday, December 4, 2025, approved the company's cash dividend for the third quarter ...

While there is no cure for Parkinson’s disease, there’s now a better way to control its involuntary muscle movements. In February, the FDA approved Medtronic’s BrainSense adaptive deep brain ...